Free Trial

Campbell & CO Investment Adviser LLC Has $1.22 Million Stock Position in Maximus, Inc. $MMS

Maximus logo with Business Services background

Key Points

  • Campbell & CO Investment Adviser LLC reduced its holdings in Maximus, Inc. by 16.8% during the first quarter, selling 3,615 shares and bringing their total ownership to 17,841 shares valued at approximately $1.22 million.
  • Maximus reported $2.16 earnings per share for the last quarter, beating estimates and achieving 2.5% revenue growth year-over-year, alongside a forecasted EPS of 6.15 for the current fiscal year.
  • The company's board member, Gayathri Rajan, sold 7,913 shares at an average price of $72.38, decreasing their stake by 35.78% and leaving them with shares valued at over $1 million.
  • Five stocks to consider instead of Maximus.

Campbell & CO Investment Adviser LLC cut its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 16.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,841 shares of the health services provider's stock after selling 3,615 shares during the quarter. Campbell & CO Investment Adviser LLC's holdings in Maximus were worth $1,217,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. LRI Investments LLC boosted its stake in shares of Maximus by 11.9% during the 1st quarter. LRI Investments LLC now owns 1,833 shares of the health services provider's stock worth $125,000 after acquiring an additional 195 shares in the last quarter. Vestcor Inc boosted its stake in shares of Maximus by 2.3% during the 1st quarter. Vestcor Inc now owns 9,877 shares of the health services provider's stock worth $674,000 after acquiring an additional 223 shares in the last quarter. Cetera Investment Advisers boosted its stake in shares of Maximus by 5.8% during the 1st quarter. Cetera Investment Advisers now owns 4,519 shares of the health services provider's stock worth $308,000 after acquiring an additional 247 shares in the last quarter. UMB Bank n.a. boosted its stake in shares of Maximus by 70.2% during the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after acquiring an additional 250 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its stake in shares of Maximus by 0.7% during the 1st quarter. Nisa Investment Advisors LLC now owns 39,936 shares of the health services provider's stock worth $2,723,000 after acquiring an additional 290 shares in the last quarter. 97.21% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on MMS. Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th. Zacks Research upgraded Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Strong Buy" and an average price target of $90.00.

View Our Latest Stock Report on MMS

Maximus Stock Up 0.4%

Shares of NYSE:MMS traded up $0.34 during trading on Monday, reaching $88.06. 434,573 shares of the company traded hands, compared to its average volume of 677,149. The firm has a fifty day simple moving average of $76.74 and a 200 day simple moving average of $71.85. The firm has a market cap of $4.96 billion, a P/E ratio of 16.22 and a beta of 0.61. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.94. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.77. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company's revenue for the quarter was up 2.5% on a year-over-year basis. During the same quarter last year, the business posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Sunday, August 31st. Stockholders of record on Friday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus's dividend payout ratio is 22.10%.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Read More

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.